<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37851974</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0987</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>The Pediatric infectious disease journal</Title><ISOAbbreviation>Pediatr Infect Dis J</ISOAbbreviation></Journal><ArticleTitle>Human Rhinovirus as a Cause of Fever in Neonates and Young Infants During the COVID-19 Pandemic, 2020-2022.</ArticleTitle><Pagination><StartPage>130</StartPage><EndPage>135</EndPage><MedlinePgn>130-135</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/INF.0000000000004139</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Human rhinovirus (HRV) was predominant and persistent during the coronavirus disease 2019 (COVID-19) pandemic despite nonpharmaceutical interventions. The data whether HRV persistence also occurred in neonates and young infants were very limited.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This prospective observational study was conducted in Niigata, Japan, between January 2020 and September 2022. The participants were hospitalized neonates and infants less than 4 months of age with fever. We excluded patients with evidence of bacterial infection or obvious sick contact with influenza or respiratory syncytial virus infection, as confirmed by rapid antigen detection tests. COVID-19 diagnosed by polymerase chain reaction (PCR) or rapid antigen detection tests were also excluded. Parechovirus and enterovirus were examined by PCR using serum and/or cerebrospinal fluid. FilmArray Respiratory Panel v1.7 was conducted on nasopharyngeal swabs. If HRV was positive, the genotype was identified.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included 72 patients (median age, 54 days; interquartile range, 28.5-79 days), and sepsis was diagnosed in 31 (43.1%) patients. In total, 27 (37.5%) patients had had positive multiplex PCR tests. These patients were more likely to have rhinorrhea ( P  = 0.004), cough ( P  = 0.01), and sick contact ( P  &lt; 0.001) than those who with negative multiplex PCR. HRV was the most frequently detected virus (n = 23, 85.2%), and species A (n = 15, 71.4%) and C (n = 6, 28.6%) were genotyped. No seasonality or monthly predominance of the specific HRV types was observed.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">HRV was an important cause of fever in neonates and young infants during the COVID-19 pandemic, 2020 to 2022.</AbstractText><CopyrightInformation>Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aizawa</LastName><ForeName>Yuta</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-0617-6456</Identifier><AffiliationInfo><Affiliation>From the Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikuse</LastName><ForeName>Tatsuki</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-0417-6797</Identifier><AffiliationInfo><Affiliation>From the Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izumita</LastName><ForeName>Ryohei</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>From the Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Niigata City General Hospital, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Habuka</LastName><ForeName>Rie</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>From the Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Niigata City General Hospital, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamanaka</LastName><ForeName>Takayuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Niigata City General Hospital, Niigata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saitoh</LastName><ForeName>Akihiko</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2404-1128</Identifier><AffiliationInfo><Affiliation>From the Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Infect Dis J</MedlineTA><NlmUniqueID>8701858</NlmUniqueID><ISSNLinking>0891-3668</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="Y">Rhinovirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005334" MajorTopicYN="Y">Fever</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010850" MajorTopicYN="Y">Picornaviridae Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>17</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>18</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>18</Day><Hour>16</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37851974</ArticleId><ArticleId IdType="doi">10.1097/INF.0000000000004139</ArticleId><ArticleId IdType="pii">00006454-990000000-00608</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Greenhow TL, Hung YY, Pantell RH. Management and outcomes of previously healthy, full-term, febrile infants ages 7 to 90 days. Pediatrics. 2016;138:e20160270.</Citation></Reference><Reference><Citation>Hayakawa I, Nomura O, Uda K, et al. Incidence and aetiology of serious viral infections in young febrile infants. J Paediatr Child Health. 2020;56:586–589.</Citation></Reference><Reference><Citation>Aizawa Y, Izumita R, Saitoh A. Human parechovirus type 3 infection: an emerging infection in neonates and young infants. J Infect Chemother. 2017;23:419–426.</Citation></Reference><Reference><Citation>de Jong EP, van den Beuken MGA, van Elzakker EPM, et al. Epidemiology of sepsis-like illness in young infants: major role of enterovirus and human parechovirus. Pediatr Infect Dis J. 2018;37:113–118.</Citation></Reference><Reference><Citation>Wolthers KC, Benschop KS, Schinkel J, et al. Human parechoviruses as an important viral cause of sepsislike illness and meningitis in young children. Clin Infect Dis. 2008;47:358–363.</Citation></Reference><Reference><Citation>Aizawa Y, Suzuki Y, Watanabe K, et al. Clinical utility of serum samples for human parechovirus type 3 infection in neonates and young infants: the 2014 epidemic in Japan. J Infect. 2016;72:223–232.</Citation></Reference><Reference><Citation>Tabatabai J, Ihling CM, Manuel B, et al. Viral etiology and clinical characteristics of acute respiratory tract infections in hospitalized children in Southern Germany (2014-2018). Open Forum Infect Dis. 2023;10:ofad110.</Citation></Reference><Reference><Citation>Kidszun A, Klein L, Winter J, et al. Viral infections in neonates with suspected late-onset bacterial sepsis-a prospective cohort study. Am J Perinatol. 2017;34:1–7.</Citation></Reference><Reference><Citation>Nagasawa K, Ishiwada N. Disease burden of respiratory syncytial virus infection in the pediatric population in Japan. J Infect Chemother. 2022;28:146–157.</Citation></Reference><Reference><Citation>Shinjoh M, Furuichi M, Kobayashi H, et al. Trends in effectiveness of inactivated influenza vaccine in children by age groups in seven seasons immediately before the COVID-19 era. Vaccine. 2022;40:3018–3026.</Citation></Reference><Reference><Citation>Andrup L, Krogfelt KA, Hansen KS, et al. Transmission route of rhinovirus - the causative agent for common cold. a systematic review. Am J Infect Control. 2023;51:938–957.</Citation></Reference><Reference><Citation>Tang JW, Bialasiewicz S, Dwyer DE, et al. Where have all the viruses gone? disappearance of seasonal respiratory viruses during the COVID-19 pandemic. J Med Virol. 2021;93:4099–4101.</Citation></Reference><Reference><Citation>Tang JW, Tellier R, Li Y. Hypothesis:All respiratory viruses (including SARS-CoV-2) are aerosol-transmitted. Indoor Air. 2022;32:e12937.</Citation></Reference><Reference><Citation>Niigata Prefecture. Population Statistics in Niigata Prefecture in 2020. Available at: https://www.pref.niigata.lg.jp/site/tokei/nenpo20201001.html . Accessed December 31, 2022.</Citation></Reference><Reference><Citation>Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6:2–8.</Citation></Reference><Reference><Citation>Nix WA, Maher K, Johansson ES, et al. Detection of all known parechoviruses by real-time PCR. J Clin Microbiol. 2008;46:2519–2524.</Citation></Reference><Reference><Citation>Mohamed N, Elfaitouri A, Fohlman J, et al. A sensitive and quantitative single-tube real-time reverse transcriptase-PCR for detection of enteroviral RNA. J Clin Virol. 2004;30:150–156.</Citation></Reference><Reference><Citation>Corey L, Huang ML, Selke S, et al. Differentiation of herpes simplex virus types 1 and 2 in clinical samples by a real-time taqman PCR assay. J Med Virol. 2005;76:350–355.</Citation></Reference><Reference><Citation>Renaud C, Crowley J, Jerome KR, et al. Comparison of FilmArray respiratory panel and laboratory-developed real-time reverse transcription-polymerase chain reaction assays for respiratory virus detection. Diagn Microbiol Infect Dis. 2012;74:379–383.</Citation></Reference><Reference><Citation>Doern CD, Lacey D, Huang R, et al. Evaluation and implementation of FilmArray version 1.7 for improved detection of adenovirus respiratory tract infection. J Clin Microbiol. 2013;51:4036–4039.</Citation></Reference><Reference><Citation>Shirato K, Nao N, Katano H, et al. Development of genetic diagnostic methods for detection for novel coronavirus 2019(nCoV-2019) in Japan. Jpn J Infect Dis. 2020;73:304–307.</Citation></Reference><Reference><Citation>Ikuse T, Aizawa Y, Takihara H, et al. Development of novel PCR assays for improved detection of enterovirus D68. J Clin Microbiol. 2021;59:e0115121.</Citation></Reference><Reference><Citation>Vlasak M, Blomqvist S, Hovi T, et al. Sequence and structure of human rhinoviruses reveal the basis of receptor discrimination. J Virol. 2003;77:6923–6930.</Citation></Reference><Reference><Citation>Ishiko H, Shimada Y, Yonaha M, et al. Molecular diagnosis of human enteroviruses by phylogeny-based classification by use of the VP4 sequence. J Infect Dis. 2002;185:744–754.</Citation></Reference><Reference><Citation>Boratyn GM, Camacho C, Cooper PS, et al. BLAST: a more efficient report with usability improvements. Nucleic Acids Res. 2013;41:W29–W33.</Citation></Reference><Reference><Citation>Chow EJ, Uyeki TM, Chu HY. The effects of the COVID-19 pandemic on community respiratory virus activity. Nat Rev Microbiol. 2023;21:195–210.</Citation></Reference><Reference><Citation>Brueggemann AB, Jansen van Rensburg MJ, Shaw D, et al. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the invasive respiratory infection surveillance initiative: a prospective analysis of surveillance data. Lancet Digit Health. 2021;3:e360–e370.</Citation></Reference><Reference><Citation>Burstein B, Anderson G, Yannopoulos A. (2021) Prevalence of serious bacterial infections among febrile infants 90 days or younger in a Canadian urban pediatric emergency department during the COVID-19 pandemic. JAMA Netw Open. 2021;4:e2116919.</Citation></Reference><Reference><Citation>Aizawa Y, Kasamatsu T, Nagasawa K, et al. Molecular evolution and epidemiology of Parechovirus-A3 in Japan, 1997-2019. J Infect Dis. 2023;227:288–294.</Citation></Reference><Reference><Citation>Hirae K, Hoshina T, Koga H. Impact of the COVID-19 pandemic on the epidemiology of other communicable diseases in Japan. Int J Infect Dis. 2023;128:265–271.</Citation></Reference><Reference><Citation>Tanaka Y, Miyata I, Nakamura Y, et al. Characteristics and etiology of infection in febrile infants aged ≤90 days. Pediatr Int. 2022;64:e15040.</Citation></Reference><Reference><Citation>Aykac K, Karadag-Oncel E, Tanir Basaranoglu S, et al. Respiratory viral infections in infants with possible sepsis. J Med Virol. 2019;91:171–178.</Citation></Reference><Reference><Citation>Huang QS, Wood T, Jelley L, et al.; NPIsImpactOnFlu Consortium. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nat Commun. 2021;12:1001.</Citation></Reference><Reference><Citation>Teo KW, Patel D, Sisodia S, et al. Rhinovirus persistence during the COVID-19 pandemic-Impact on pediatric acute wheezing presentations. J Med Virol. 2022;94:5547–5552.</Citation></Reference><Reference><Citation>Rankin DA, Spieker AJ, Perez A, et al.; NVSN Network Investigators. Circulation of rhinoviruses and/or enteroviruses in pediatric patients with acute respiratory illness before and during the COVID-19 pandemic in the US. JAMA Netw Open. 2023;6:e2254909.</Citation></Reference><Reference><Citation>Takashita E, Kawakami C, Momoki T, et al. Increased risk of rhinovirus infection in children during the coronavirus disease-19 pandemic. Influenza Other Respir Viruses. 2021;15:488–494.</Citation></Reference><Reference><Citation>Leung NHL, Chu DKW, Shiu EYC, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med. 2020;26:676–680.</Citation></Reference><Reference><Citation>Dreschers S, Dumitru CA, Adams C, et al. The cold case: are rhinoviruses perfectly adapted pathogens? Cell Mol Life Sci. 2007;64:181–191.</Citation></Reference><Reference><Citation>Woo PCY, de Groot RJ, Haagmans B, et al. ICTV virus taxonomy profile: coronaviridae 2023. J Gen Virol. 2023;104:001843.</Citation></Reference><Reference><Citation>Noda T, Sagara H, Yen A, et al. Architecture of ribonucleoprotein complexes in influenza a virus particles. Nature. 2006;439:490–492.</Citation></Reference><Reference><Citation>Kim HM, Lee EJ, Lee NJ, et al. Impact of coronavirus disease 2019 on respiratory surveillance and explanation of high detection rate of human rhinovirus during the pandemic in the Republic of Korea. Influenza Other Respir Viruses. 2021;15:721–731.</Citation></Reference><Reference><Citation>Jia R, Lu L, Li S, et al. Human rhinoviruses prevailed among children in the setting of wearing face masks in Shanghai, 2020. BMC Infect Dis. 2022;22:253.</Citation></Reference><Reference><Citation>Chow EJ, Casto AM, Roychoudhury P, et al. The clinical and genomic epidemiology of rhinovirus in homeless Shelters-King County, Washington. J Infect Dis. 2022;226:S304–S314.</Citation></Reference><Reference><Citation>Weinberg GA, Hall CB, Iwane MK, et al.; New Vaccine Surveillance Network. Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization. J Pediatr. 2009;154:694–699.</Citation></Reference><Reference><Citation>Aizawa Y, Takanashi S, Ogimi C. Updates on coronavirus disease 2019 in children in Japan. Pediatr Infect Dis J. 2022;41:e461–e467.</Citation></Reference><Reference><Citation>Ujiie M, Tsuzuki S, Nakamoto T, et al. Resurgence of respiratory syncytial virus infections during COVID-19 pandemic, Tokyo, Japan. Emerg Infect Dis. 2021;27:2969–2970.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>